Fig. 1.

Resveratrol intake improves endothelial function and reduces platelet hyperaggregation in MTHFR C677T carriers. A Flow-mediated dilation evaluation before and after resveratrol of subjects in our study population divided by genotype (wild type, CC, N = 10; heterozygous, CT, N = 14; and homozygous, TT, N = 13). B Quantification of platelet aggregation presented as percentage of light transmission of platelets from control (CTRL) and MTHFR carrier subjects. Data are shown are mean ± SEM. *p < 0.05. Statistical analysis was determined by paired two-tailed Student’s t test